Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on ...

Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...

In a move aimed at protecting patients as artificial intelligence increasingly enters healthcare, govt has brought AI-based ...

AccurKardia, an ECG-led diagnostics software company focused on transforming ECG data into a more powerful diagnostic tool ...

Liability framework health systems clarifies AI accountability across developers, clinicians and health systems to reduce risk and support adoption.

Johnson & Johnson today announced that the company has submitted the OTTAVAtm Robotic Surgical System to the U.S. Food and Drug Administration (FDA) in an application for De Novo classification.

As artificial intelligence becomes more prevalent in healthcare, the central government has decided to bring AI-based cancer ...

DCGI releases classification of 77 medical devices related to oncology: Gireesh Babu, New Delhi Wednesday, January 7, 2026, 08:00 Hrs [IST] As part of its efforts to regulate the ...

Owkin, the AI company on a mission to solve the complexity of biology, today announced the launch of its agentic ...

Medera Inc. ('Medera'), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...

Anthropic's rollout of a healthcare product for Claude comes one week after OpenAI announced some similar features for ...

A new development in wireless sensing technology which can reliably screen for five common pulmonary diseases could lead to breakthrough new forms of touch-free diagnostics.